🎁 FREE BONUS: Attendees will be eligible for a complimentary consultation with a Perpetual Health Navigator to help create a personalized plan for supporting brain-body health.
Join Dr. Dayan Goodenowe for a comprehensive discussion about the latest research on multiple sclerosis and new scientific evidence of biochemical resilience and recovery mechanisms.
Every day, approximately 300 people worldwide receive a diagnosis of multiple sclerosis. That’s someone diagnosed every five minutes.
In the United States alone, 1 million people face the reality that current disease-modifying therapies delay progression but do not stop it.
This false reassurance often prevents people with MS from exploring the biochemical interventions that may actually support white matter restoration and remyelination.
Why do some MS patients maintain function while others decline rapidly—even on the same treatments? The answer lies in biochemical mechanisms most neurologists never discuss.
But that’s exactly what this presentation explores.
MS is the most common inflammatory demyelinating disease in young adults, affecting women at 3 times the rate of men. Most diagnoses occur between ages 20-50—peak productivity years.
Over the past three decades, MS prevalence has climbed 26% and more than doubled in some regions.
Yet most people affected by MS are told their options remain limited to symptom management. Groundbreaking research reveals something different: MS represents specific biochemical disruptions that may respond to targeted support—not just immune suppression.
MS is the most common inflammatory demyelinating disease in young adults, affecting women at 3 times the rate of men. Most diagnoses occur between ages 20-50—peak productivity years.
Yet groundbreaking research reveals something different: MS represents specific biochemical disruptions that may respond to targeted support—not just immune suppression.
NOVEMBER 5th, 4PM PACIFIC
MS involves more than immune system attacks on myelin. The real devastation comes from what happens next.
When myelin (the protective coating around nerve fibers) is damaged, your brain faces an energy crisis. The brain consumes 20% of your body’s oxygen despite representing just 2% of your weight. When MS strips away myelin, energy demands skyrocket as neurons struggle to maintain basic function.
The result? Debilitating fatigue, cognitive fog, and progressive dysfunction as neurons literally run out of fuel.
Traditional therapies manage immune response. But what about the energy crisis? What about supporting your brain’s natural repair capacity?
MS prevalence has jumped from 2.3 million to 2.9 million globally in just over a decade. In the United States, we see one of the world’s highest rates: 353-377 cases per 100,000 people depending on region.
Over 450 Americans receive an MS diagnosis every week.
Average annual care costs hit $88,000 per patient—yet these treatments manage symptoms rather than address underlying biochemical dysfunction.
Dr. Goodenowe’s research into these mechanisms matters because understanding how to support white matter integrity and cellular energy has implications far beyond MS alone.
Average annual care costs for treating MS hit $88,000 per patient—yet these treatments manage symptoms rather than address underlying biochemical dysfunction.
Dr. Goodenowe’s research into these mechanisms matters because understanding how to support white matter integrity and cellular energy has implications far beyond MS alone.
Dr. Goodenowe presents MS research that will challenge conventional understanding and provide cutting-edge scientific insights into white matter resilience and remyelination.
Join hundreds of MS patients, caregivers, and healthcare professionals discovering new perspectives on neurological health.
NOVEMBER 5th AT 4 PM PACIFIC
World-Renowned Neuroscientist & Bestselling Author
Dr. Dayan Goodenowe is a world-renowned neuroscientist whose research into the biochemical mechanisms of disease started in 1990. His curiosity about the biochemistry of life remains as insatiable today as it was over three decades ago.
Dr. Goodenowe invented and developed advanced diagnostic and bioinformatic technologies, designed and manufactured novel biochemical precursors, and identified biochemical prodromes of numerous diseases including Alzheimer’s disease and dementia, Parkinson’s disease, multiple sclerosis, stroke, autism, amyotrophic lateral sclerosis (ALS), schizophrenia, bipolar disorder, depression, and multiple types of cancer.
As the founder of Prodrome Science and author of the bestselling book “Breaking Alzheimer’s,” Dr. Goodenowe’s research focuses on identifying and correcting the biochemical imbalances that affect brain function – long before symptoms become irreversible.
His current focus is to defeat the entropy of aging by creating strategic biochemical and biofunctional reserve capacity in advance of known disease risks, enabling the human body to maintain optimal physical and biological functions.
As the founder of Prodrome Science and author of the bestselling book "Breaking Alzheimer's," Dr. Goodenowe's research focuses on identifying and correcting the biochemical imbalances that affect brain function—long before symptoms become irreversible.
His current focus is to defeat the entropy of aging by creating strategic biochemical and biofunctional reserve capacity in advance of known disease risks, enabling the human body to maintain optimal physical and biological functions.
This presentation offers evidence-based insights into MS that go beyond immunosuppression to explore genuine biochemical support and white matter repair pathways.
🎁 FREE BONUS: Attendees will be eligible for a complimentary consultation with a Perpetual Health Navigator to help create a personalized plan for supporting brain-body health.
Whether you have MS, are caring for someone with the condition, or work with individuals facing neuroinflammation and demyelination, this presentation will provide you with direct, scientific insights backed by decades of biochemical research.
You won’t want to miss this conversation. Hear the discussion live and participate in the Q&A with one of the world’s leading experts in brain biochemistry.
GROUNDBREAKING RESEARCH REVEALED
"Dr. Goodenowe's research has completely changed how we understand brain health. His scientific approach provides hope and practical pathways forward that go far beyond traditional treatments"
"Finally, someone who explains the biochemistry behind neurodegeneration in a way that makes sense and offers real strategies for supporting brain function at the cellular level."
"I am an Apollo Health Coach with a background in Bio/chem, and when I listened to Dr. Goodenowe's research, I was fascinated, intrigued and blown away. My heart beats for science, and his work has started to 'hang together' in ways that make real sense."
"Dr. Goodenowe's approach to brain biochemistry is revolutionary. He doesn't just talk about managing symptoms—he addresses the underlying mechanisms that can make a real difference in people's lives"
Join hundreds of families and professionals who are discovering new pathways for supporting brain-body health, white matter integrity, and neurological resilience in MS.
Every day, 300 people worldwide receive an MS diagnosis. Prevalence has climbed 26% over three decades. With 2.9 million people living with MS globally, research into biochemical mechanisms and remyelination has never been more urgent.
This live presentation happens only once: November 5th at 4PM Pacific.
NOVEMBER 5th AT 4 PM PACIFIC
This webinar is presented by Perpetual Health. Dr. Goodenowe’s research-based insights are grounded in peer-reviewed science and clinical experience.